These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 312821)

  • 21. B lymphocyte activation by insoluble anti-immunoglobulin: induction of immunoglobulin secretion by a T cell-dependent soluble factor.
    Parker DC; Fothergill JJ; Wadsworth DC
    J Immunol; 1979 Aug; 123(2):931-41. PubMed ID: 379222
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
    Hiserodt JC
    J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural cytotoxicity against mouse hepatitis virus-infected cells. II. A cytotoxic effector cell with a B lymphocyte phenotype.
    Welsh RM; Haspel MV; Parker DC; Holmes KV
    J Immunol; 1986 Feb; 136(4):1454-60. PubMed ID: 3003199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new B cell differentiation antigen (BDA) on normal and leukemic human B lymphocytes that is distinct from known DR (Ia-like) antigens.
    Balch CM; Dougherty PA; Vogler LB; Ades EW; Ferrone S
    J Immunol; 1978 Dec; 121(6):2322-8. PubMed ID: 102693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody-dependent cellular cytotoxicity effector cells lack Ia antigens.
    Nelson DL; Sachs DH; Dickler HB
    J Immunol; 1977 Sep; 119(3):1034-40. PubMed ID: 330744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surface immunoglobulin and Fc receptors on murine B lymphocytes: loss of receptor interaction after cell activation.
    Scribner DJ; Weiner HL; Moorhead JW
    J Immunol; 1977 Dec; 119(6):2084-8. PubMed ID: 334982
    [No Abstract]   [Full Text] [Related]  

  • 27. Anti-lymphocyte antibodies in systemic lupus erythematosus.
    Winfield JB
    Clin Rheum Dis; 1985 Dec; 11(3):523-49. PubMed ID: 3907954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The differentiation of the effect of anti-human IgM on lymphocytes in vitro].
    Schwenke H; von Baehr R; Storch H
    Allerg Immunol (Leipz); 1973; 19(2-4):226-32. PubMed ID: 4281627
    [No Abstract]   [Full Text] [Related]  

  • 29. In vitro correlates of cell-mediated immunity in the human.
    Bach JF
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:161-73. PubMed ID: 4277530
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunoglobulin-independent natural cytotoxicity of Fc receptor-bearing human blood lymphocytes to mumps virus-infected target cells.
    Härfast B; Andersson T; Perlmann P
    J Immunol; 1978 Aug; 121(2):755-61. PubMed ID: 308078
    [No Abstract]   [Full Text] [Related]  

  • 31. Different phenotypic variants of the mouse B cell tumor A20/2J are selected by antigen- and mitogen-triggered cytotoxicity of L3T4-positive, I-A-restricted T cell clones.
    Jones B; Tite JP; Janeway CA
    J Immunol; 1986 Jan; 136(1):348-56. PubMed ID: 2415625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human monocyte, lymphocyte, and granulocyte antibody-dependent cell-mediated cytotoxicity toward tumor cells. I. General characteristics of cytolysis.
    Levy PC; Shaw GM; LoBuglio AF
    J Immunol; 1979 Aug; 123(2):594-9. PubMed ID: 458149
    [No Abstract]   [Full Text] [Related]  

  • 33. The detection of Ia-like and DRw antigens on activated T cells.
    Zimmermann R; Ozer H; DeWolf WC; Evans RL; Yunis EJ; Schlossman SF
    Transplant Proc; 1979 Dec; 11(4):1770-3. PubMed ID: 93803
    [No Abstract]   [Full Text] [Related]  

  • 34. Anti-idiotype antibodies to the 9.1C3 blocking antibody used to probe the lethal hit stage of NK cell-mediated cytolysis.
    Werkmeister JA; Burns GF; Triglia T
    J Immunol; 1984 Sep; 133(3):1385-90. PubMed ID: 6611373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphocyte functions and subpopulation distribution in marmosets.
    Wallen WC; Claysmith AP; Cicmanec JL
    Primates Med; 1978; 10():184-92. PubMed ID: 417319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different lymphocyte populations in rheumatoid arthritis and their relationship to anti-Ig activities.
    Natvig JB; Froland SS; Wisloff F; Munthe E
    Ann Clin Res; 1975 Jun; 7(3):146-53. PubMed ID: 1081361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polyclonal B cell activation by B cell differentiation factor B151-TRF2. I. Involvement of self-Ia recognition process mediated by B cells.
    Ono S; Takahama Y; Hamaoka T
    J Immunol; 1986 Aug; 137(4):1149-56. PubMed ID: 3090140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro immune response of human peripheral lymphocytes. IV. Specific induction of human suppressor T cells by an antiserum to the T leukemia cell line HSB.
    Hirano T; Kishimoto T; Kuritani T; Muraguchi A; Yamamura Y; Ralph P; Good RA
    J Immunol; 1979 Sep; 123(3):1133-40. PubMed ID: 313946
    [No Abstract]   [Full Text] [Related]  

  • 39. Ontogeny of lymphocyte functions during embryonic life of the rabbit.
    Cazenave PA; Juy D; Bona C
    J Immunol; 1978 Aug; 121(2):444-8. PubMed ID: 681742
    [No Abstract]   [Full Text] [Related]  

  • 40. Surface markers for lymphocyte subpopulations.
    Stobo JD
    J Lab Clin Med; 1978 Jan; 91(1):9-11. PubMed ID: 304083
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.